A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation

S. H. Lin, C. J. Cheng, Y. C. Lee, X. Ye, W. W. Tsai, J. Kim, R. Pasqualini, W. Arap, N. M. Navone, S. M. Tu, M. Hu, L. Y. Yu-Lee, C. J. Logothetis

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

ErbB3 is a transmembrane growth factor receptor that has been implicated in the pathogenesis of human cancer. After finding that a truncated form of ErbB3 was present and upregulated in metastatic prostate cancer cells in lymph nodes and bone, we explored the pathophysiological functions of this unusual form of ErbB3 in the context of mouse calvaria as well as osteoblasts in vitro and the femur microenvironment in vivo. Here we demonstrate that prostate cancer cells expressed an alternatively spliced transcript that encodes a 45-kDa glycosylated protein (p45-sErbB3). The recombinant p45-sErbB3 purified from conditioned medium stimulated calvarial bone formation and induced osteoblast differentiation. Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice. Further, we detected sErbB3 in plasma samples from patients with castration-resistant prostate cancer with bone metastasis. These observations establish that p45-sErbB3 is a structurally and functionally unique gene product of ErbB3 and suggest that p45-sErbB3 is likely one of the factors involved in the osteoblastic bone metastases of prostate cancer.

Original languageEnglish (US)
Pages (from-to)5195-5203
Number of pages9
JournalOncogene
Volume27
Issue number39
DOIs
StatePublished - Sep 4 2008

Fingerprint

Osteogenesis
Prostatic Neoplasms
Bone and Bones
Osteoblasts
Femur
Neoplasm Metastasis
Bone Neoplasms
Growth Factor Receptors
Castration
Conditioned Culture Medium
Skull
Lymph Nodes
Phenotype
Cell Line
Injections
Genes
Neoplasms
Proteins

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Keywords

  • Bone metastasis
  • Osteoblast
  • Prostate cancer
  • p45-sErbB3

Cite this

Lin, S. H., Cheng, C. J., Lee, Y. C., Ye, X., Tsai, W. W., Kim, J., ... Logothetis, C. J. (2008). A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene, 27(39), 5195-5203. https://doi.org/10.1038/onc.2008.156
Lin, S. H. ; Cheng, C. J. ; Lee, Y. C. ; Ye, X. ; Tsai, W. W. ; Kim, J. ; Pasqualini, R. ; Arap, W. ; Navone, N. M. ; Tu, S. M. ; Hu, M. ; Yu-Lee, L. Y. ; Logothetis, C. J. / A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. In: Oncogene. 2008 ; Vol. 27, No. 39. pp. 5195-5203.
@article{fac65507839a40de888e8a6d2b942630,
title = "A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation",
abstract = "ErbB3 is a transmembrane growth factor receptor that has been implicated in the pathogenesis of human cancer. After finding that a truncated form of ErbB3 was present and upregulated in metastatic prostate cancer cells in lymph nodes and bone, we explored the pathophysiological functions of this unusual form of ErbB3 in the context of mouse calvaria as well as osteoblasts in vitro and the femur microenvironment in vivo. Here we demonstrate that prostate cancer cells expressed an alternatively spliced transcript that encodes a 45-kDa glycosylated protein (p45-sErbB3). The recombinant p45-sErbB3 purified from conditioned medium stimulated calvarial bone formation and induced osteoblast differentiation. Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice. Further, we detected sErbB3 in plasma samples from patients with castration-resistant prostate cancer with bone metastasis. These observations establish that p45-sErbB3 is a structurally and functionally unique gene product of ErbB3 and suggest that p45-sErbB3 is likely one of the factors involved in the osteoblastic bone metastases of prostate cancer.",
keywords = "Bone metastasis, Osteoblast, Prostate cancer, p45-sErbB3",
author = "Lin, {S. H.} and Cheng, {C. J.} and Lee, {Y. C.} and X. Ye and Tsai, {W. W.} and J. Kim and R. Pasqualini and W. Arap and Navone, {N. M.} and Tu, {S. M.} and M. Hu and Yu-Lee, {L. Y.} and Logothetis, {C. J.}",
year = "2008",
month = "9",
day = "4",
doi = "10.1038/onc.2008.156",
language = "English (US)",
volume = "27",
pages = "5195--5203",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "39",

}

Lin, SH, Cheng, CJ, Lee, YC, Ye, X, Tsai, WW, Kim, J, Pasqualini, R, Arap, W, Navone, NM, Tu, SM, Hu, M, Yu-Lee, LY & Logothetis, CJ 2008, 'A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation', Oncogene, vol. 27, no. 39, pp. 5195-5203. https://doi.org/10.1038/onc.2008.156

A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. / Lin, S. H.; Cheng, C. J.; Lee, Y. C.; Ye, X.; Tsai, W. W.; Kim, J.; Pasqualini, R.; Arap, W.; Navone, N. M.; Tu, S. M.; Hu, M.; Yu-Lee, L. Y.; Logothetis, C. J.

In: Oncogene, Vol. 27, No. 39, 04.09.2008, p. 5195-5203.

Research output: Contribution to journalArticle

TY - JOUR

T1 - A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation

AU - Lin, S. H.

AU - Cheng, C. J.

AU - Lee, Y. C.

AU - Ye, X.

AU - Tsai, W. W.

AU - Kim, J.

AU - Pasqualini, R.

AU - Arap, W.

AU - Navone, N. M.

AU - Tu, S. M.

AU - Hu, M.

AU - Yu-Lee, L. Y.

AU - Logothetis, C. J.

PY - 2008/9/4

Y1 - 2008/9/4

N2 - ErbB3 is a transmembrane growth factor receptor that has been implicated in the pathogenesis of human cancer. After finding that a truncated form of ErbB3 was present and upregulated in metastatic prostate cancer cells in lymph nodes and bone, we explored the pathophysiological functions of this unusual form of ErbB3 in the context of mouse calvaria as well as osteoblasts in vitro and the femur microenvironment in vivo. Here we demonstrate that prostate cancer cells expressed an alternatively spliced transcript that encodes a 45-kDa glycosylated protein (p45-sErbB3). The recombinant p45-sErbB3 purified from conditioned medium stimulated calvarial bone formation and induced osteoblast differentiation. Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice. Further, we detected sErbB3 in plasma samples from patients with castration-resistant prostate cancer with bone metastasis. These observations establish that p45-sErbB3 is a structurally and functionally unique gene product of ErbB3 and suggest that p45-sErbB3 is likely one of the factors involved in the osteoblastic bone metastases of prostate cancer.

AB - ErbB3 is a transmembrane growth factor receptor that has been implicated in the pathogenesis of human cancer. After finding that a truncated form of ErbB3 was present and upregulated in metastatic prostate cancer cells in lymph nodes and bone, we explored the pathophysiological functions of this unusual form of ErbB3 in the context of mouse calvaria as well as osteoblasts in vitro and the femur microenvironment in vivo. Here we demonstrate that prostate cancer cells expressed an alternatively spliced transcript that encodes a 45-kDa glycosylated protein (p45-sErbB3). The recombinant p45-sErbB3 purified from conditioned medium stimulated calvarial bone formation and induced osteoblast differentiation. Overexpression of p45-sErbB3 in the osteolytic prostate cancer cell line PC-3 converted its phenotype from bone lysing to bone forming upon injection into the femurs of immunodeficient mice. Further, we detected sErbB3 in plasma samples from patients with castration-resistant prostate cancer with bone metastasis. These observations establish that p45-sErbB3 is a structurally and functionally unique gene product of ErbB3 and suggest that p45-sErbB3 is likely one of the factors involved in the osteoblastic bone metastases of prostate cancer.

KW - Bone metastasis

KW - Osteoblast

KW - Prostate cancer

KW - p45-sErbB3

UR - http://www.scopus.com/inward/record.url?scp=51349102459&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51349102459&partnerID=8YFLogxK

U2 - 10.1038/onc.2008.156

DO - 10.1038/onc.2008.156

M3 - Article

C2 - 18490922

AN - SCOPUS:51349102459

VL - 27

SP - 5195

EP - 5203

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 39

ER -

Lin SH, Cheng CJ, Lee YC, Ye X, Tsai WW, Kim J et al. A 45-kDa ErbB3 secreted by prostate cancer cells promotes bone formation. Oncogene. 2008 Sep 4;27(39):5195-5203. https://doi.org/10.1038/onc.2008.156